siRNA, Anti-PPP2R5A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT17544WQ-2F)
The product SIRGT17544WQ-2F is a type of small interfering RNA (siRNA) that targets PPP2R5A gene and regulates the expression of gene. The siRNA interferes with the expression of PPP2R5A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_001199756.1; NM_006243.3 |
| Alternative Names | B56A; B56alpha; PR61A |
| Related Diseases | Progressive Familial Heart Block, Type Ii |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT18544WQ-2MOE | PPP2R5A | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT19544WQ-LNA | PPP2R5A | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT86995WQ-2OMe | Ppp2r5a | Mouse | 2ʹ-O-methyl (2'-OMe) | ||
| SIRGT87995WQ-2F | Ppp2r5a | Mouse | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT89995WQ-LNA | Ppp2r5a | Mouse | Locked Nucleic Acid (LNA) | ||
| SIRGT16544WQ-RB | PPP2R5A | Human | Ribo-modified | ||
| SIRGT17544WQ-BB | PPP2R5A | Human | Backbone-modified | ||
| SIRGT87995WQ-BB | Ppp2r5a | Mouse | Backbone-modified |
